1800-272-662
Shopping Cart 0
countryflagAU
Login

Anagenics Ltd

Consumer Defensive AU AN1

0.007AUD
-(-%)

Last update at 2026-03-11T23:00:00Z

Day Range

0.0070.007
LowHigh

52 Week Range

0.0040.009
LowHigh

Fundamentals

  • Previous Close 0.007
  • Market Cap6.90M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA0.20M
  • Revenue TTM4.83M
  • Revenue Per Share TTM0.01
  • Gross Profit TTM 2.32M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -1.23568M -7.28422M -2.19644M -3.64400M -3.75989M
Minority interest - - - - -
Net income -1.23568M -7.49321M -2.66715M -3.64879M -3.38663M
Selling general administrative 2.50M 7.87M 4.12M 5.85M 0.06M
Selling and marketing expenses 0.45M 2.58M 1.75M 2.38M 5.89M
Gross profit 2.04M 4.36M 4.05M 5.07M 3.70M
Reconciled depreciation 0.20M 0.62M 0.36M 0.49M 0.45M
Ebit -1.19517M -7.21790M -1.91746M -2.29851M -3.06815M
Ebitda -0.99477M -6.60163M -1.55764M -1.80383M -2.61563M
Depreciation and amortization 0.20M 0.62M 0.36M 0.49M 0.45M
Non operating income net other - - - - -
Operating income -1.31959M -7.37678M -1.91746M -2.29851M -3.06815M
Other operating expenses 6.07M 14.23M 11.03M 13.80M 10.34M
Interest expense 0.04M 0.07M 0.03M 0.07M 0.05M
Tax provision 0.00000M 0.00000M 0.00787M 0.00478M 0.05M
Interest income 0.00265M 0.02M 0.02M 0.03M 0.02M
Net interest income -0.03786M -0.06632M -0.00958M -0.04152M -0.03148M
Extraordinary items 0.00000M -0.20899M -0.92546M -2.00532M 0.42M
Non recurring - - - - -
Other items - - - - -
Income tax expense - 0.21M -0.45475M 0.00478M 0.05M
Total revenue 4.75M 10.80M 9.11M 9.23M 5.82M
Total operating expenses 3.36M 7.17M 5.97M 9.63M 8.23M
Cost of revenue 2.71M 6.44M 5.06M 4.17M 2.11M
Total other income expense net 0.08M 0.09M -0.27898M 0.46M 0.34M
Discontinued operations - - -0.92546M -2.00532M 0.42M
Net income from continuing ops -1.23568M -7.28422M -1.74169M -3.64879M -3.80493M
Net income applicable to common shares -1.23568M -7.49321M -2.66715M -3.64879M -3.38663M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 4.10M 6.45M 11.11M 12.92M 13.29M
Intangible assets 0.00144M - 0.00144M 0.02M 1.43M
Earning assets - - - - -
Other current assets - 0.32M 0.05M 0.12M 0.22M
Total liab 2.28M 3.74M 2.22M 4.64M 2.86M
Total stockholder equity 1.83M 2.71M 8.90M 8.29M 10.43M
Deferred long term liab - - - - -
Other current liab - 0.23M 0.59M 2.25M 0.64M
Common stock - 66.83M 65.36M 62.44M 60.28M
Capital stock 67.18M - 65.36M 62.44M 60.28M
Retained earnings -65.29742M -64.06175M -56.56854M -53.90139M -50.77746M
Other liab - - 0.04M 0.12M 0.10M
Good will 1.95M 1.95M 3.45M 3.45M -
Other assets - 0.00000M 0.58M - -
Cash 0.40M 1.62M 2.57M 3.28M 6.73M
Cash and equivalents - - 2.57M 3.28M 6.73M
Total current liabilities 2.19M 3.43M 1.71M 3.66M 1.92M
Current deferred revenue - 0.40M - - -
Net debt 0.15M -0.85128M - -1.52774M -5.29392M
Short term debt - 0.47M 0.00000M 0.90M 0.59M
Short long term debt 0.54M - - 0.56M 0.34M
Short long term debt total - 0.77M - 1.76M 1.43M
Other stockholder equity - -0.00000M 0.11M -0.24408M 0.93M
Property plant equipment - - 0.77M 0.58M 0.53M
Total current assets 1.94M 4.09M 6.25M 8.77M 11.29M
Long term investments - - - - -
Net tangible assets - - 5.38M 4.71M 8.96M
Short term investments - - - - -
Net receivables 0.63M 0.67M 1.04M 0.92M 1.80M
Long term debt - - 0.00000M 0.77M 0.60M
Inventory 0.97M 1.48M 2.40M 4.45M 2.55M
Accounts payable 1.06M 2.33M 0.72M 0.50M 0.68M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - -0.05958M - -0.24408M 0.93M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.00144M 0.58M - -
Deferred long term asset charges - - - - -
Non current assets total 2.16M 2.36M 4.86M 4.15M 2.01M
Capital lease obligations 0.31M - 0.65M 0.43M 0.49M
Long term debt total - - 0.46M 0.85M 0.84M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments 0.00000M -0.19790M -1.50875M -0.96820M 0.48M
Change to liabilities - - -0.18285M -1.07450M -0.43682M
Total cashflows from investing activities 0.00000M -0.19790M -1.50875M -0.96820M 0.48M
Net borrowings 0.54M - -0.34279M 0.10M -0.57939M
Total cash from financing activities 0.35M 0.99M 2.56M 0.07M 3.50M
Change to operating activities - - -0.12585M -0.15575M -1.00844M
Net income -1.23568M -7.28422M -1.74169M -1.64347M -3.38663M
Change in cash -1.22841M -0.94314M -0.71779M -3.44291M -0.24320M
Begin period cash flow 1.62M 2.57M 3.28M 6.73M 6.97M
End period cash flow 0.40M 1.62M 2.57M 3.28M 6.73M
Total cash from operating activities -1.57612M -1.73832M -1.78049M -2.54934M -4.11415M
Issuance of capital stock - 1.36M 3.18M - 4.51M
Depreciation - 0.62M 0.36M 0.38M 0.43M
Other cashflows from investing activities 0.00000M -0.10000M -0.61978M -0.93226M 0.50M
Dividends paid - - 0.27M - 0.05M
Change to inventory 0.17M 1.14M 0.04M 0.28M -0.27416M
Change to account receivables 0.04M 0.86M -0.05269M 1.32M -0.05973M
Sale purchase of stock 0.00000M -0.14927M -0.27143M 0.00000M -0.37899M
Other cashflows from financing activities -0.19673M -0.02876M 0.22M 0.63M -0.26064M
Change to netincome - - 0.87M 0.26M 0.60M
Capital expenditures 0.00000M 0.10M 0.05M 0.04M 0.02M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.28194M 1.97M -0.31925M 0.37M 0.93M
Stock based compensation - - 0.02M 0.22M 0.16M
Other non cash items -1.29419M 2.96M 0.83M -1.42595M 1.69M
Free cash flow -1.57612M -1.83622M -1.82586M -2.58529M -0.02247M

Peer Comparison

Sector: Consumer Defensive Industry: Household & Personal Products

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AN1
Anagenics Ltd		 - -% 0.007 - 4.97 1.43 3.04 1.81 -3.9793
S66
Star Combo Pharma Ltd		 0.01 7.32% 0.22 5.13 - 1.15 0.72 0.58 1.75
MCP
Mcphersons Ltd		 - -% 0.18 - 16.08 0.19 0.37 0.14 16.32
ZNO
ZOONO Group Ltd		 -0.003 5.56% 0.05 - 8.88 20.96 6.31 23.28 -1.3808
SKN
Skin Elements Ltd		 - -% 0.006 - - 53.24 11.48 47.73 -0.216

Reports Covered

Stock Research & News

View All

Profile

Anagenics Limited engages in the health wellness and beauty business. The company develops, manufactures, and markets anti-ageing hair care products under the évolis brand name; and skin, hair, and body care products under the Uspa brand name. It also imports and distributes skin care and wellbeing products to spas, clinics, salons, retail stores, and online in Australia, New Zealand, and the Pacific Islands. The company was formerly known as Cellmid Limited and changed its name to Anagenics Limited in December 2021. Anagenics Limited was incorporated in 2004 and is based in Sydney, Australia.

Anagenics Ltd

68 Pitt Street, Sydney, NSW, Australia, 2000

Key Executives

Name Title Year Born
Mr. Matthew Dudek Acting Chief Exec. Officer NA
Mr. Dominic Burg Chief Operating Officer NA
Ms. Carolyn Heath Chief Customer Officer & GM of Sales NA
Dr. Graham Robertson Head of R&D NA
Mr. Scott Mitchell Greasley Exec. Director NA
Mr. Lee Tamplin B.A. Company Sec. NA
Mr. Scott Mitchell Greasley CEO, MD & Executive Director NA
Mr. Matthew Dudek Chief Financial & Governance Officer and Company Secretary NA
Dr. Graham Robertson Head of Research & Development NA
Mr. Scott Mitchell Greasley CEO, MD & Executive Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.